mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |